We are live on ! Find out more
AIM

Acrospire Investment Management Portfolio holdings

AUM $33K
1-Year Est. Return 23.36%
This Fund
S&P 500
This Quarter Est. Return
+5.13%
1 Year Est. Return
+23.36%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$107M
AUM Growth
-$14.5M
Cap. Flow
-$16.8M
Cap. Flow %
-15.73%
Top 10 Hldgs %
2.69%
Holding
2,904
New
705
Increased
558
Reduced
830
Closed
739

Top Buys

Rank Stock Value
1
PG icon
Procter & Gamble
PG
+$423K
2
GIS icon
General Mills
GIS
+$314K
3
MO icon
Altria Group
MO
+$234K
4
PX
Praxair Inc
PX
+$231K
5
ATR icon
AptarGroup
ATR
+$231K

Sector Composition

Rank Sector Weight
1 Industrials 15.12%
2 Healthcare 14.17%
3 Financials 13.11%
4 Consumer Discretionary 12.41%
5 Technology 11.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PG icon
1
Procter & Gamble
PG
$343B
$418K 0.39%
+4,800
New +$423K
GIS icon
2
General Mills
GIS
$19.2B
$355K 0.33%
6,400
+5,500
+611% +$314K
WMT icon
3
Walmart Inc
WMT
$871B
$303K 0.28%
12,000
+900
+8% +$22.8K
K
4
DELISTED
Kellanova
K
$292K 0.27%
4,470
+1,704
+62% +$115K
PEP icon
5
PepsiCo
PEP
$186B
$277K 0.26%
2,400
+2,000
+500% +$229K
CPB icon
6
Campbell Soup
CPB
$6.51B
$258K 0.24%
4,945
+3,500
+242% +$198K
CCK icon
7
Crown Holdings
CCK
$12.8B
$249K 0.23%
4,181
+3,981
+1,991% +$225K
ATR icon
8
AptarGroup
ATR
$8.45B
$243K 0.23%
+2,800
New +$231K
JNJ icon
9
Johnson & Johnson
JNJ
$635B
$238K 0.22%
1,800
+1,600
+800% +$204K
MO icon
10
Altria Group
MO
$122B
$238K 0.22%
+3,200
New +$234K
PX
11
DELISTED
Praxair Inc
PX
$238K 0.22%
+1,799
New +$231K
SJM icon
12
J.M. Smucker
SJM
$12.6B
$237K 0.22%
2,000
+1,700
+567% +$215K
CAG icon
13
Conagra Brands
CAG
$7.07B
$235K 0.22%
6,584
+2,100
+47% +$81.3K
SLGN icon
14
Silgan Holdings
SLGN
$4.91B
$231K 0.22%
7,282
+6,600
+968% +$204K
MDT icon
15
Medtronic
MDT
$107B
$224K 0.21%
2,525
+2,000
+381% +$169K
TWX
16
DELISTED
Time Warner Inc
TWX
$221K 0.21%
2,200
+2,000
+1,000% +$198K
INGR icon
17
Ingredion
INGR
$6.38B
$215K 0.2%
1,801
+1,000
+125% +$119K
ECL icon
18
Ecolab
ECL
$75.6B
$212K 0.2%
1,600
+1,400
+700% +$181K
HUN icon
19
Huntsman Corp
HUN
$2.24B
$212K 0.2%
8,208
+200
+2% +$4.95K
CL icon
20
Colgate-Palmolive
CL
$72.6B
$208K 0.2%
+2,800
New +$208K
SXT icon
21
Sensient Technologies
SXT
$5.4B
$208K 0.2%
2,584
+1,400
+118% +$113K
WM icon
22
Waste Management
WM
$95.9B
$205K 0.19%
2,800
+2,100
+300% +$153K
WBA
23
DELISTED
Walgreens Boots Alliance
WBA
$201K 0.19%
2,571
+2,499
+3,471% +$206K
PFE icon
24
Pfizer
PFE
$140B
$198K 0.19%
6,219
+4,006
+181% +$126K
RTX icon
25
RTX Corp
RTX
$287B
$195K 0.18%
+2,542
New +$190K

Similar funds

Acrospire Investment Management's Q2 2017 Portfolio in Review

As of Q2 2017, Acrospire Investment Management held 2,904 positions worth $107M, down 12% from $121M the previous quarter. Its ten largest holdings account for 2.7% of the portfolio.

Acrospire Investment Management withdrew a net $16.8M in Q2 2017, closing 739 positions and reducing 830 holdings. Its most notable exit was Bunge Global, an estimated $285K position sold in full.

By sector, the portfolio is most concentrated in Industrials at 15% of assets, up from 15% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Acrospire Investment Management opened a new position in Procter & Gamble worth $418K.

  • Acrospire Investment Management's largest Q2 2017 buy was Procter & Gamble: 4,800 shares worth $418K.
  • Acrospire Investment Management added most to General Mills in Q2 2017, an estimated $314K increase.
  • Acrospire Investment Management's biggest Q2 2017 reduction was Navios Maritime Acquisition Corporation, cutting an estimated $1.35M.
  • Acrospire Investment Management fully exited Bunge Global in Q2 2017, selling an estimated $285K.
  • Acrospire Investment Management's ten largest holdings make up 2.7% of its $107M portfolio in Q2 2017.
  • Acrospire Investment Management opened 705 new positions and closed 739 in Q2 2017.
  • Acrospire Investment Management's portfolio value fell 12% quarter-over-quarter to $107M.

Based on Acrospire Investment Management's 13F filing for Q2 2017, filed 11 Aug 2017.